Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus

Insulin Analogues ◽

Acting Insulin

Children Randomized to Long-Acting Insulin Glargine or Determir from Diagnosis of Type 1 Diabetes Mellitus Have Lower HbA1c after One Year as Compared to Those Randomized to NPH Insulin

10.1210/endo-meetings.2011.part4.p4.p3-478 ◽

2011 ◽

pp. P3-478-P3-478

Author(s):

Peter Bang ◽

Jenny Salemyr ◽

Klas Ekstrom ◽

Anna-Lena Brorsson ◽

Mari-Anne Pulkkinen ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Nph Insulin ◽

Acting Insulin ◽

One Year ◽

Glycaemic Control and Hypoglycaemia in Children, Adolescents and Young Adults with Unstable Type 1 Diabetes Mellitus Treated with Insulin Glargine or Intermediate-acting Insulin

Journal of Pediatric Endocrinology and Metabolism ◽

10.1515/jpem.2007.20.4.517 ◽

2007 ◽

Vol 20 (4) ◽

Cited By ~ 9

Author(s):

J. Herwig ◽

G. Scholl-Schilling ◽

H. Böhles

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Young Adults ◽

Glycaemic Control ◽

Insulin Glargine ◽

Acting Insulin ◽

Intermediate Acting Insulin ◽

Unstable Type

Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus

10.1002/14651858.cd012161 ◽

2016 ◽

Cited By ~ 13

Author(s):

Birgit Fullerton ◽

Andrea Siebenhofer ◽

Klaus Jeitler ◽

Karl Horvath ◽

Thomas Semlitsch ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Human Insulin ◽

Insulin Analogues ◽

Regular Human Insulin ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin

Rapid-Acting Insulin Analogues in Basal-Bolus Regimens in Type 1 Diabetes Mellitus

Endocrine Practice ◽

10.4158/ep09294.ra ◽

2010 ◽

Vol 16 (3) ◽

pp. 486-505 ◽

Cited By ~ 10

Author(s):

Satish Garg ◽

Francisco Ampudia-Blasco ◽

Martin Pfohl

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Analogues ◽

Acting Insulin ◽

Basal Bolus

Definitions and reporting of hypoglycaemia in trials of long-acting insulin analogues in people with type 1 diabetes mellitus

10.1002/14651858.cd013824 ◽

2020 ◽

Author(s):

Emil Ørskov Ipsen ◽

Bianca Hemmingsen ◽

Lasse Østrup Petersen ◽

Maria-Inti Metzendorf ◽

Bernd Richter

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Analogues ◽

Acting Insulin ◽

(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus

10.1002/14651858.cd013498 ◽

2019 ◽

Cited By ~ 1

Author(s):

Bianca Hemmingsen ◽

Bernd Richter ◽

Maria-Inti Metzendorf

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Analogues ◽

Acting Insulin ◽

Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen

Terapevticheskii arkhiv ◽

10.17116/terarkh2015871042-49 ◽

2015 ◽

Vol 87 (10) ◽

pp. 42

Author(s):

N. V. Efremova ◽

L. L. Bolotskaya ◽

D. S. Atarshchikov ◽

O. N. Bondarenko ◽

A. V. Ilyin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Young Patients ◽

Insulin Analogues ◽

Insulin Glulisine ◽

Basal Bolus ◽

Observational Program

Insulin Glargine Versus Intermediate-Acting Insulin as the Basal Component of Multiple Daily Injection Regimens for Adolescents with Type 1 Diabetes Mellitus

The Journal of Pediatrics ◽

10.1016/j.jpeds.2008.04.063 ◽

2008 ◽

Vol 153 (4) ◽

pp. 547-553.e3 ◽

Cited By ~ 36

Author(s):

H. Peter Chase ◽

Silva Arslanian ◽

Neil H. White ◽

William V. Tamborlane

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Daily Injection ◽

Multiple Daily Injection ◽

Acting Insulin ◽

Intermediate Acting Insulin

(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus

10.1002/14651858.cd013498.pub2 ◽

2021 ◽

Author(s):

Bianca Hemmingsen ◽

Maria-Inti Metzendorf ◽

Bernd Richter

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Analogues ◽

Acting Insulin ◽

Acylated-based long-acting insulin analogues: Is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes

Diabetes & Metabolism ◽

10.1016/j.diabet.2014.10.001 ◽

2014 ◽

Vol 40 (6) ◽

pp. 483-484 ◽

Cited By ~ 1

Author(s):

L. Monnier ◽

C. Colette ◽

D. Owens

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Analogues ◽

Insulin Degludec ◽

Insulin Antibody ◽

Daily Insulin ◽

Acting Insulin ◽